FIELD: medicine, biochemistry, pharmacy. SUBSTANCE: invention proposes pharmaceutical composition for reduction of content of ceramides based on L-carnitine or acyl-L-carnitine, or L-carnitine and acyl-L-carnitine and nucleoside-like inhibitor of reverse transcriptase, non-nucleoside-like inhibitor of reverse transcriptase, or inhibitor of HIV-protease. Compositions are used for treatment of patients with HIV-infection, AIDS due to decrease of ceramide content, viral loading and enhancement of immune activity of patients. EFFECT: expanded assortment of agents of indicated designation. 8 cl, 4 tbl, 4 ex
Authors
Dates
2003-04-27—Published
1996-07-19—Filed